citation,pmid
"Borrmann S, Adegnika AA, Matsiegui P-B, Issifou S, Schindler A, Mawili-Mboumba DP, et al. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. J Infect Dis. 2004 Mar 1;189(5):901–8.",14976608
"Borrmann S, Lundgren I, Oyakhirome S, Impouma B, Matsiegui P-B, Adegnika AA, et al. Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2006 Aug;50(8):2713–8.",16870763
Hunter WN. The non-mevalonate pathway of isoprenoid precursor biosynthesis. J Biol Chem. 2007 Jul 27;282(30):21573–7.,17442674
"Ruangweerayut R, Looareesuwan S, Hutchinson D, Chauemung A, Banmairuroi V, Na-Bangchang K. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria. Malar J. 2008 Oct 31;7:225.",18973702
"Wiemer AJ, Hsiao C-HC, Wiemer DF. Isoprenoid metabolism as a therapeutic target in gram-negative pathogens. Curr Top Med Chem. 2010;10(18):1858–71.",20615187
Hunter WN. Isoprenoid precursor biosynthesis offers potential targets for drug discovery against diseases caused by apicomplexan parasites. Curr Top Med Chem. 2011;11(16):2048–59.,21619509
"Yeh E, DeRisi JL. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 2011 Aug;9(8):e1001138.",21912516
"Wu W, Herrera Z, Ebert D, Baska K, Cho SH, DeRisi JL, et al. A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis. Antimicrob Agents Chemother. 2015 Jan;59(1):356–64.",25367906
"Yao Z-K, Krai PM, Merino EF, Simpson ME, Slebodnick C, Cassera MB, et al. Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure-activity studies. Bioorg Med Chem Lett. 2015 Apr 1;25(7):1515–9.",25754494
